本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Zentalis Pharmaceuticals, LLC

1.47
+0.11008.09%
盘后1.470.00000.00%16:30 EDT
成交量:160.81万
成交额:233.09万
市值:1.06亿
市盈率:-0.63
高:1.48
开:1.39
低:1.36
收:1.36
数据加载中...
2024/06/21

重要事件披露

Form 8-K - Current report
2024/06/03

重要事件披露

Form 8-K - Current report
2024/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/29

重要事件披露

Form 8-K - Current report
2024/05/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/11

重要事件披露

Form 8-K - Current report
2024/04/09

重要事件披露

Form 8-K - Current report
2024/02/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/27

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/27

重要事件披露

Form 8-K - Current report
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/15

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]